A new personalized vaccine given in combination with another drug has reduced the chances of a type of skin cancer returning ...

The last time you heard of Moderna (MRNA) was likely because of its mRNA Covid vaccine, but that same tech, once administered ...

The experimental mRNA vaccine successfully cleared phase 3 clinical trials, the last step necessary before it can be approved ...

The success of Moderna and Merck’s intismeran autogene doesn’t guarantee smooth sailing for other mRNA vaccine developers ...

Nevertheless, in the past year, Merck (MRK) delivered an impressive 73% return to investors, outpacing the S&P 500. The peak ...

Earlier this week, biotechnology company Amplitude Therapeutics announced a partnership with global pharmaceutical ...

President Donald Trump’s announcement this week of White House aide Heidi Overton as his pick to lead the FDA gave the pharma ...

Moderna and Merck's neoantigen treatment, combining a personalized mRNA cancer vaccine with the immunotherapy drug ...

The results, announced this week by Moderna and Merck, could pave the way for a new generation of treatments tailored to ...

Moderna has now swung violently in both directions for three straight sessions on the same unchanged clinical news, and the ...

The Centers for Disease Control and Prevention has brought on a communications and public affairs official who appears to ...

Early results from final-stage trial of individualised melanoma jab offer hope of more tailor-made cancer treatments ...